title: [Improvement of hemorheology with ginkgo biloba extract. Decreasing a cardiovascular risk factor].
abstract: METHODS
  Open prospective study.
  
  
  METHODS
  20 outpatients with a long history of elevated fibrinogen levels and plasma viscosity, and a variety of underlying diseases.
  
  
  METHODS
  Treatment with the special ginkgo biloba extract (EGb 761), 240 mg tablets a day for a period of 12 weeks.
  
  
  RESULTS
  The clinical diagnoses included coronary heart disease, hypertension, hypercholesterolemia and diabetes mellitus. A significant improvement in the fibrinogen levels and hemorrheological properties was seen. The medication can thus positively influence these cardiovascular risk factors over the long term.
authors.affiliation: Medizinische Abteilung, Diakonissen-Krankenhaus Karlsruhe Rüppurr.
authors.forename: S
authors.initials: S
authors.lastname: Witte
authors.forename: I
authors.initials: I
authors.lastname: Anadere
authors.forename: E
authors.initials: E
authors.lastname: Walitza
mesh_terms: D000368:Aged; D001809:Blood Viscosity / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000097:blood / Q000628:therapy*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism*; D020441:Ginkgo biloba; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000627:therapeutic use*; D011446:Prospective Studies; D012212:Rheology; D012307:Risk Factors; D000096983:Ginkgo Extract
chemical_list: D005340:Fibrinogen; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract
vernacular_title: Verbesserung der Hämorheologie durch Ginkgo-biloba-Extrakt. Verminderung eines kardiovaskulären Risikofaktors.